P. Roy Vagelos, Chairman of the Board at REGENERON PHARMACEUTICALS INC (REGN), sold 18,908 shares at $459.24 ($8.1M) on 2017-05-25, disclosed to the SEC on 2017-05-26.
Open-market sale of $8.1M REGN by Chairman of the Board. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 571 | $0 | 0.0% |
| 2 | $0.00 | 547 | $0 | 0.0% |
| 3 | $457.58 | 3,510 | $1.6M | 19.7% |
| 4 | $457.58 | 3,510 | $1.6M | 19.7% |
| 5 | $458.35 | 4,985 | $2.3M | 28.0% |
| 6 | $458.35 | 4,985 |
| $2.3M |
| 28.0% |
| 7 | $459.24 | 800 | $367K | 4.5% |
| Total | $431.00 avg | 18,908 | $8.1M | 100% |
| Filing → |
| REGN | SELL | 2020-08-13 | $39.7M | — | Filing → |
| REGN | SELL | 2020-05-22 | $168.0M | — | Filing → |
| REGN | SELL | 2020-05-22 | $847K | — | Filing → |